Premium Grade | UK Supply | Research Peptide | COA Certified | >99% Purity | Worldwide Delivery

(Pentapeptide–5 Amino Acids)

Brief Summary

Ipamorelin is a peptide research compound studied in laboratory settings for its interaction with growth hormone secretagogue receptors and related endocrine signalling pathways. It is commonly examined in controlled investigational models focused on receptor selectivity, secretion pathway activity, and comparative peptide mechanism analysis. Within scientific supply catalogues, Ipamorelin is valued for in vitro and preclinical research involving signalling dynamics, marker observation, and structured study design. Its role in research centres on analytical investigation, documented laboratory handling, and consistent experimental planning, making it suitable for professional scientific environments requiring clear, research focused presentation and dependable peptide supply standards.

Product Overview

Ipamorelin is a synthetic pentapeptide belonging to the growth hormone secretagogue (GHS) class, specifically designed to selectively stimulate endogenous growth hormone release through activation of the ghrelin (GHS-R1a) receptor. Unlike GHRH analogues, Ipamorelin operates via a distinct receptor pathway, allowing researchers to study growth hormone modulation without directly engaging the hypothalamic GHRH system. Within research environments, Ipamorelin is recognised for its high receptor selectivity and minimal interaction with non-growth hormone pathways. This selectivity makes it particularly valuable for investigations focused on isolated growth hormone signalling, endocrine specificity, and controlled modulation of the GH–IGF-1 axis. Its clean pharmacological profile allows researchers to explore growth hormone dynamics with reduced confounding hormonal activity. Ipamorelin's stability, predictable receptor behaviour, and short-to-moderate activity profile have established it as an important research peptide for examining growth hormone secretion patterns, signalling efficiency, and downstream metabolic processes.

Scientific Background

Ipamorelin is structurally engineered as a ghrelin mimetic, binding selectively to the growth hormone secretagogue receptor (GHS-R1a) expressed on pituitary somatotroph cells. Upon receptor activation, Ipamorelin initiates intracellular signalling cascades involving phospholipase C and calcium mobilisation, leading to pulsatile release of growth hormone independent of GHRH stimulation. One of the defining scientific characteristics of Ipamorelin is its limited effect on other pituitary hormones such as prolactin, adrenocorticotropic hormone, and cortisol. This high level of specificity allows researchers to isolate growth hormone–related mechanisms without widespread endocrine disruption, making Ipamorelin especially useful in mechanistic and comparative hormone studies. Downstream of growth hormone release, Ipamorelin indirectly influences insulin-like growth factor-1 (IGF-1) production, a key mediator of cellular growth, protein synthesis, and metabolic regulation. This pathway enables detailed investigation of GH–IGF-1 signalling fidelity, receptor sensitivity, and endocrine efficiency in controlled experimental settings.

Research Applications

Ipamorelin is extensively researched in endocrinology and metabolic science, particularly in studies examining selective growth hormone stimulation and receptor specific signalling. Researchers utilise Ipamorelin to investigate ghrelin receptor dynamics, growth hormone pulsatility, and the comparative effects of GHS compounds versus GHRH analogues. In metabolic research, Ipamorelin is explored for its indirect role in lipid metabolism regulation, energy utilisation pathways, and nutrient partitioning driven by growth hormone activity. Its selective profile allows for focused investigation of growth hormone mediated metabolic processes without interference from additional pituitary hormone fluctuations. Additionally, Ipamorelin is used in research examining cellular repair pathways, protein turnover, and tissue maintenance processes linked to growth hormone signalling. Its receptor specificity and controlled activity make it well suited for long-term experimental models assessing endocrine precision, adaptive hormone responses, and growth hormone receptor regulation.

Technical Specifications

• Contents: 10mg Ipamorelin
• Form: Lyophilized powder
• Purity: >99% (HPLC Verified)
• Molecular Formula: C₃₈H₄₉N₉O
• Sequence: Ala‑Trp‑D-Phe‑Lys‑Asn‑NH₂
• Peptide Length: 5 Amino‑Acids
• pH Range: 4.0–7.4
• Storage: Store between 2°C and 8°C

Note: Reconstitute with Bacteriostatic (BAC) Water 10ml for best results.

Explore Related Research Compounds

Continue exploring currently available BioPlex compounds associated with growth-hormone secretagogue signalling, GHRH pathways and comparative peptide research.

View CJC-1295 + Ipamorelin 10mg Research Peptide Blend ⟶

View CJC-1295 10mg + Ipamorelin 10mg Research Set ⟶

View HGH Fragment 176-191 5mg Research Peptide ⟶

Explore BioPlex Research Information

Use BioPlex educational tools and guidance covering peptide calculations, preparation, reconstitution, classification and storage.

Use the BioPlex Peptide Calculator ⟶

Read the Peptide Calculator Guide ⟶

Read the Peptide Reconstitution Guide ⟶

Explore Peptide Types & Storage Guidance ⟶

Explore Related Research Articles

Continue exploring BioPlex educational resources covering Ipamorelin, growth-hormone secretagogue signalling and related peptide pathways.

Read the Ipamorelin Peptide Research Overview ⟶

Read Growth Hormone Secretagogues Research ⟶

Read CJC-1295 + Ipamorelin: GH Pulsatility, IGF-1 and Myogenic Markers ⟶

Disclaimer

For research purposes only. Not for human consumption